C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
C12N 15/863 (2006.01) A61K 39/00 (2006.01) A61K 39/39 (2006.01)
Patent
CA 2595629
The present invention is directed to a recombinant MVA, which carries a nucleic acid sequence coding for a fusion protein. The present invention is further directed to a kit of parts containing said recombinant MVA as well as to a method for enhancing T cell responses in a mammal.
La présente invention concerne un MVA recombiné, qui comporte une séquence nucléotidique codant pour une protéine de fusion. La présente invention concerne en outre un kit en plusieurs parties contenant ledit MVA recombiné ainsi qu'un procédé d'amplification des réponses des lymphocytes T chez un mammifère.
Drexler Ingo
Erfle Volker
Gasteiger Georg
Sutter Gerd
Gsf-Forschungszentrum Fuer Umwelt Und Gesundheit Gmbh
Helmholtz Zentrum Muenchen Deutsches Forschungszentrum Fuer Gesu
Oyen Wiggs Green & Mutala Llp
LandOfFree
Vaccines based on the use of mva does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Vaccines based on the use of mva, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Vaccines based on the use of mva will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-2010789